Memorial for a radiopharmaceutical – Azedra or No carrier added [131I]-MIBG
Sign Up to like & getrecommendations! Published in 2025 at "Canadian Journal of Chemistry"
DOI: 10.1139/cjc-2025-0187
Abstract: Azedra is the name given to high specific activity/ high molar activity MIBG (m-[131I]-(iodobenzylguanindinium); iobenguane (131I) produced commercially for the treatment of adrenal carcinoma: neuroblastoma, pheochromocytoma and paraganglioma. Azedra was patented in 2007; human clinical… read more here.
Keywords: radiopharmaceutical azedra; carrier added; azedra carrier; memorial radiopharmaceutical ... See more keywords